Literature DB >> 33541259

Increased expression of MUSASHI1 in epithelial breast cancer cells is due to down regulation of miR-125b.

Mahboobeh Forouzanfar1, Liana Lachinani2, Kianoush Dormiani2, Mohammad Hossein Nasr-Esfahani3, Kamran Ghaedi4.   

Abstract

BACKGROUND: Musashi1 (MSI1) is an oncogenic protein with a crucial role in the proliferation and characteristics of the epithelial cells in breast cancer. The change in expression of MSI1 has a role in solid tumor progression. There are different factors that regulate MSI1 expression in various cancer tissues including microRNAs which are considered as one of the most important of these factors. The aim of our study is identification of the molecular cause of maximal expression of MSI1 in epithelial breast cancer cell lines.
RESULTS: Among predicted microRNAs, miR-125b, miR-637 and miR-802 were able to significantly reduce the luciferase activity. In addition, the relative expression of these three miRNAs were measured in the cancerous cell lines that results showed a significant reduction in expression of all microRNAs. On the other hand, only the overexpression of miR-125b caused a change in the expression pattern of MSI1 in breast epithelial cancer cell lines. Accordingly, our results demonstrated that the exogenous expression of miR-125b decreased not only the MSI1 protein but also expression of epithelial markers in breast cancer cells.
CONCLUSIONS: The results of luciferase reporter assay showed that MSI1 is a direct target for miR-125b in epithelial breast cancer cells. Moreover, higher amount of MSI1 in those cell lines seems due to the reduced amount of miR-125b, which is responsible for epithelial features of those kinds of cancer cells. Therefore, the modulation of miR-125b may be a potential approach to help to combat against epithelial breast tumors.

Entities:  

Keywords:  Breast cancer; Epithelial markers; Musashi1; microRNA

Year:  2021        PMID: 33541259     DOI: 10.1186/s12860-021-00348-8

Source DB:  PubMed          Journal:  BMC Mol Cell Biol        ISSN: 2661-8850


  40 in total

1.  Musashi1 promotes tumor metastasis and is a prognostic marker for renal carcinoma.

Authors:  Ruihai Xiao; Yi Yu; Shaochen Shen; Fei Liu; Renrui Kuang
Journal:  Int J Clin Exp Pathol       Date:  2019-01-01

2.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

3.  Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways.

Authors:  Xiao-Yang Wang; Yuzhi Yin; Hongyan Yuan; Toshiyuki Sakamaki; Hideyuki Okano; Robert I Glazer
Journal:  Mol Cell Biol       Date:  2008-03-24       Impact factor: 4.272

4.  The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis.

Authors:  Dat T Vo; Dharmalingam Subramaniam; Marc Remke; Tarea L Burton; Philip J Uren; Jonathan A Gelfond; Raquel de Sousa Abreu; Suzanne C Burns; Mei Qiao; Uthra Suresh; Andrey Korshunov; Adrian M Dubuc; Paul A Northcott; Andrew D Smith; Stefan M Pfister; Michael D Taylor; Sarath C Janga; Shrikant Anant; Christine Vogel; Luiz O F Penalva
Journal:  Am J Pathol       Date:  2012-09-14       Impact factor: 4.307

5.  RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways.

Authors:  Jun Muto; Takao Imai; Daisuke Ogawa; Yoshinori Nishimoto; Yohei Okada; Yo Mabuchi; Takeshi Kawase; Akio Iwanami; Paul S Mischel; Hideyuki Saya; Kazunari Yoshida; Yumi Matsuzaki; Hideyuki Okano
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

6.  Musashi-1 promotes a cancer stem cell lineage and chemoresistance in colorectal cancer cells.

Authors:  Guang-Yuh Chiou; Tzu-Wei Yang; Chi-Chou Huang; Chia-Ying Tang; Jung-Yi Yen; Ming-Chang Tsai; Hsuan-Yi Chen; Nurul Fadhilah; Chun-Che Lin; Yuh-Jyh Jong
Journal:  Sci Rep       Date:  2017-05-19       Impact factor: 4.379

7.  Musashi-1 Enhances Glioblastoma Migration by Promoting ICAM1 Translation.

Authors:  Jang-Chun Lin; Jo-Ting Tsai; Tsu-Yi Chao; Hsin-I Ma; Wei-Hsiu Liu
Journal:  Neoplasia       Date:  2019-04-06       Impact factor: 5.715

Review 8.  Musashi: a translational regulator of cell fate.

Authors:  Hideyuki Okano; Takao Imai; Masataka Okabe
Journal:  J Cell Sci       Date:  2002-04-01       Impact factor: 5.285

9.  Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer.

Authors:  Xiao-Yang Wang; Huina Yu; R Ilona Linnoila; Laodong Li; Dangyu Li; Biwen Mo; Hideyuki Okano; Luiz O F Penalva; Robert I Glazer
Journal:  Oncotarget       Date:  2013-05

10.  Musashi-1 promotes stress-induced tumor progression through recruitment of AGO2.

Authors:  Hsiao-Yun Chen; Mong-Lien Wang; Benoit Laurent; Chih-Hung Hsu; Ming-Teh Chen; Liang-Ting Lin; Jia Shen; Wei-Chao Chang; Jennifer Hsu; Mien-Chie Hung; Yi-Wei Chen; Pin-I Huang; Yi-Ping Yang; Chung-Pin Li; Hsin-I Ma; Chung-Hsuan Chen; Wen-Chang Lin; Shih-Hwa Chiou
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

View more
  2 in total

Review 1.  Regulatory mechanisms and potential medical applications of HNF1A-AS1 in cancers.

Authors:  Yang Zhang; Jiang Shi; Junfang Luo; Cong Liu; Lixu Zhu
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

Review 2.  Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis.

Authors:  Jinze Shen; Chenhao Liang; Xinming Su; Qurui Wang; Yufei Ke; Jie Fang; Dayong Zhang; Shiwei Duan
Journal:  Biomark Res       Date:  2022-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.